Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PAOX | Q6QHF9 | 2/20 | 0.38 |
| ▸ | MTNR1A | P48039 | 3/20 | 0.33 |
| ▸ | MTNR1B | P49286 | 3/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 2/20 | 0.31 |
| ▸ | USP2 | O75604 | 1/20 | 0.31 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.30 |
| ▸ | POLB | P06746 | 1/20 | 0.30 |
| ▸ | KIF11 | P52732 | 1/20 | 0.30 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13915083 | 0.92 | MEN1 (0.37) | MTNR1AMTNR1BMEN1KMT2AMAPK1 | |
| SCHEMBL13915151 | 0.92 | ALDH1A1 (0.34) | MEN1KMT2AALDH1A1SMN1; SMN2POLB | |
| SCHEMBL11938246 | 0.89 | PAOX (0.33) | PAOX | |
| SCHEMBL11938264 | 0.87 | MEN1 (0.35) | MEN1KMT2AKIF11 | |
| SCHEMBL11938262 | 0.87 | MEN1 (0.35) | MEN1KMT2AKIF11 | |
| SCHEMBL13915116 | 0.82 | — | — | |
| SCHEMBL8056741 | 0.82 | PAOX (0.52) | PAOXMTNR1AMTNR1BMEN1KMT2A | |
| SCHEMBL13915159 | 0.81 | TLR2 (0.31) | MEN1KMT2A | |
| SCHEMBL13915168 | 0.81 | MEN1 (0.33) | MTNR1AMTNR1BMEN1KMT2ATSHR | |
| SCHEMBL13915081 | 0.81 | SMN1; SMN2 (0.30) | MTNR1AMTNR1BSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090074673-A1 | Compositions and methods for producing cellular labels for nuclear magnetic resonance techniques | CARNEGIE MELLON UNIVERSITY (US) | 2009-03-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090074673-A1 | Compositions and methods for producing cellular labels for nuclear magnetic resonance techniques | NES, MKI67, CD68 | PAOX 2129/4885MTNR1A 1680/4885MTNR1B 1475/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.